155 related articles for article (PubMed ID: 9500720)
1. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity.
Mathurin P; Moussalli J; Cadranel JF; Thibault V; Charlotte F; Dumouchel P; Cazier A; Huraux JM; Devergie B; Vidaud M; Opolon P; Poynard T
Hepatology; 1998 Mar; 27(3):868-72. PubMed ID: 9500720
[TBL] [Abstract][Full Text] [Related]
2. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
[TBL] [Abstract][Full Text] [Related]
3. Persistently normal alanine aminotransferase levels in HIV/HCV-coinfected patients: the role of steatosis.
Bani-Sadr F; Barange K; Daoud F; Jacomet C; Bicart-See A; Rosenthal E; Cacoub P; Pol S; Perronne C; Carrat F;
HIV Med; 2009 Aug; 10(7):417-21. PubMed ID: 19490173
[TBL] [Abstract][Full Text] [Related]
4. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation.
Sterling RK; Sanyal AJ; Luketic VA; Stravitz RT; King AL; Post AB; Mills AS; Contos MJ; Shiffman ML
Am J Gastroenterol; 1999 Dec; 94(12):3576-82. PubMed ID: 10606322
[TBL] [Abstract][Full Text] [Related]
5. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied.
Espinosa M; Martin-Malo A; Alvarez de Lara MA; Soriano S; Aljama P
Clin Nephrol; 2000 Aug; 54(2):151-6. PubMed ID: 10968693
[TBL] [Abstract][Full Text] [Related]
6. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels.
Puoti C; Magrini A; Stati T; Rigato P; Montagnese F; Rossi P; Aldegheri L; Resta S
Hepatology; 1997 Dec; 26(6):1393-8. PubMed ID: 9397976
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States.
Jamal MM; Soni A; Quinn PG; Wheeler DE; Arora S; Johnston DE
Hepatology; 1999 Nov; 30(5):1307-11. PubMed ID: 10534355
[TBL] [Abstract][Full Text] [Related]
8. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
[TBL] [Abstract][Full Text] [Related]
9. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
Sánchez-Conde M; Berenguer J; Miralles P; Alvarez F; Carlos Lopez J; Cosin J; Pilar C; Ramirez M; Gutierrez I; Alvarez E
Clin Infect Dis; 2006 Sep; 43(5):640-4. PubMed ID: 16886160
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus-infected patients with a persistently normal alanine aminotransferase: do they exist and is this really a group with mild disease?
Lawson A;
J Viral Hepat; 2010 Jan; 17(1):51-8. PubMed ID: 19656289
[TBL] [Abstract][Full Text] [Related]
11. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.
Martinot-Peignoux M; Boyer N; Cazals-Hatem D; Pham BN; Gervais A; Le Breton V; Levy S; Degott C; Valla DC; Marcellin P
Hepatology; 2001 Nov; 34(5):1000-5. PubMed ID: 11679971
[TBL] [Abstract][Full Text] [Related]
12. Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT.
Kyrlagkitsis I; Portmann B; Smith H; O'Grady J; Cramp ME
Am J Gastroenterol; 2003 Jul; 98(7):1588-93. PubMed ID: 12873583
[TBL] [Abstract][Full Text] [Related]
13. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
[TBL] [Abstract][Full Text] [Related]
14. Chronic hepatitis C in patients with persistently normal alanine transaminase levels.
Shiffman ML; Diago M; Tran A; Pockros P; Reindollar R; Prati D; Rodríguez-Torres M; Lardelli P; Blotner S; Zeuzem S
Clin Gastroenterol Hepatol; 2006 May; 4(5):645-52. PubMed ID: 16630770
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years.
Persico M; Perrotta S; Persico E; Terracciano L; Folgori A; Ruggeri L; Nicosia A; Vecchione R; Mura VL; Masarone M; Torella R
J Viral Hepat; 2006 May; 13(5):290-6. PubMed ID: 16637858
[TBL] [Abstract][Full Text] [Related]
16. HCV and HGV infection, iron overload and liver disease in multitransfused patients with thalassaemia and persistently normal or abnormal transaminase levels.
Gamberini MR; Francesconi R; Fortini M; Cavazzini L; Lari F; Scapoli C; Ballardini G; De Sanctis V; Bianchi FB
Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():259-66. PubMed ID: 16462707
[TBL] [Abstract][Full Text] [Related]
17. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
18. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities.
Silini E; Bono F; Cividini A; Cerino A; Bruno S; Rossi S; Belloni G; Brugnetti B; Civardi E; Salvaneschi L
Hepatology; 1995 Feb; 21(2):285-90. PubMed ID: 7843695
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus infection acquired in childhood.
Camarero C; Ramos N; Moreno A; Asensio A; Mateos ML; Roldan B
Eur J Pediatr; 2008 Feb; 167(2):219-24. PubMed ID: 17464514
[TBL] [Abstract][Full Text] [Related]
20. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
